T. Rowe Price Investment Management Inc. 13D and 13G filings for Insmed Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-16 5:43 pm Sale | 2023-12-31 | 13G | Insmed Incorporated INSM | T. Rowe Price Investment Management Inc. | 5,850,606 4.100% | -27,378,148![]() (-82.39%) | Filing |
2024-02-14 10:04 am Purchase | 2023-12-31 | 13G | Insmed Incorporated INSM | T. Rowe Price Investment Management Inc. | 33,228,754 4.100% | 24,854,079![]() (+296.78%) | Filing |
2023-02-14 12:40 pm Purchase | 2022-12-31 | 13G | Insmed Incorporated INSM | T. Rowe Price Investment Management Inc. | 8,374,675 6.200% | 8,374,675![]() (New Position) | Filing |